Zobrazeno 1 - 10
of 713
pro vyhledávání: '"Toze CL"'
Autor:
Wan BA; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Lindo L; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Mourad YA; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Chung S; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Forrest D; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Kuchenbauer F; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Nantel S; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Narayanan S; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Nevill T; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Power M; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Rodrigo J; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Sanford D; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Song K; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Stubbins RJ; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Sutherland H; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Toze CL; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., White J; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Roy C; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada., Hay KA; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, British Columbia, Canada; Leukemia/Bone Marrow Transplant Program of BC, Vancouver, British Columbia, Canada; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: kevin.hay@ucalgary.ca.
Publikováno v:
Cytotherapy [Cytotherapy] 2024 Oct; Vol. 26 (10), pp. 1210-1216. Date of Electronic Publication: 2024 May 08.
Autor:
Khelifi RS; Department of Experimental Medicine, University of British Columbia, Vancouver, Canada., Huang SJ; Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology, Vancouver General Hospital, BC Cancer, University of British Columbia, Vancouver, Canada., Savage KJ; Centre for Lymphoid Cancer, BC Cancer, Division of Medical Oncology, University of British Columbia, Vancouver, Canada., Villa D; Centre for Lymphoid Cancer, BC Cancer, Division of Medical Oncology, University of British Columbia, Vancouver, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Division of Medical Oncology, University of British Columbia, Vancouver, Canada., Ramadan K; St. Paul's Hospital, Division of Hematology, University of British Columbia, Vancouver, Canada., Connors JM; Centre for Lymphoid Cancer, BC Cancer, Division of Medical Oncology, University of British Columbia, Vancouver, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer, Division of Medical Oncology, University of British Columbia, Vancouver, Canada., Toze CL; Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology, Vancouver General Hospital, BC Cancer, University of British Columbia, Vancouver, Canada., Gerrie AS; Department of Experimental Medicine, University of British Columbia, Vancouver, Canada.; Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology, Vancouver General Hospital, BC Cancer, University of British Columbia, Vancouver, Canada.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Jun; Vol. 64 (6), pp. 1129-1138. Date of Electronic Publication: 2023 Apr 22.
Autor:
Zhu K; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Jamroz A; Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada., Huang S; Leukemia/Bone Marrow Transplant Program of BC and Division of Hematology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Villa D; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Centre, Tampa, Florida, USA., Scott DW; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Slack G; Department of Pathology and Laboratory Medicine, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Sehn LH; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Connors JM; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Toze CL; Leukemia/Bone Marrow Transplant Program of BC and Division of Hematology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Savage KJ; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Gerrie AS; Centre for Lymphoid Cancer and Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (4), pp. 684-692. Date of Electronic Publication: 2022 May 14.
Autor:
Roy C; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, Canada. Electronic address: claudie.roy@bccancer.bc.ca., Lai EJ; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, Canada; Department of Medicine, University of British Columbia Division of Community Internal Medicine, Royal Columbian Hospital, New Westminster, Canada., Lee AHA; Department of Medicine, University of British Columbia Division of Community Internal Medicine, Royal Columbian Hospital, New Westminster, Canada., Schutz P; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, Canada., Maguire J; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, Canada., Toze CL; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, Canada., Nevill TJ; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, Canada., Abou Mourad YR; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, Vancouver, Canada.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e459-e462. Date of Electronic Publication: 2022 Jan 08.
Autor:
Stubbins RJ; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Center, BC Cancer Research Center, Vancouver, British Columbia, Canada., Stamenkovic M; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Roy C; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Rodrigo J; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Chung S; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Kuchenbauer FC; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Terry Fox Lab, BC Cancer Research Center, Vancouver, British Columbia, Canada., Hay KA; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Terry Fox Lab, BC Cancer Research Center, Vancouver, British Columbia, Canada., White J; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Abou Mourad Y; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Power MM; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Narayanan S; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Forrest DL; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Toze CL; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Sutherland HJ; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Nantel SH; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Nevill TJ; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Karsan A; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Center, BC Cancer Research Center, Vancouver, British Columbia, Canada., Song KW; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Sanford DS; Leukaemia/BMT Program of BC, BC Cancer, Vancouver, British Columbia, Canada.; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Publikováno v:
European journal of haematology [Eur J Haematol] 2022 May; Vol. 108 (5), pp. 437-445. Date of Electronic Publication: 2022 Feb 14.
Autor:
Huang SJ; Division of Hematology, Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada., Gerrie AS; British Columbia Cancer - Vancouver, The University of British Columbia, Vancouver, British Columbia, Canada., Young S; BC Cancer Genetics and Genomics Laboratory, Pathology and Laboratory Medicine, BC Cancer, The University of British Columbia, Vancouver, British Columbia, Canada., Tucker T; BC Cancer Genetics and Genomics Laboratory, Pathology and Laboratory Medicine, BC Cancer, The University of British Columbia, Vancouver, British Columbia, Canada., Bruyère H; Division of Pathology and Laboratory Medicine, Cytogenetics Laboratory, Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada., Hrynchak M; Molecular Cytogenetic Laboratory, Royal Columbian Hospital, The University of British Columbia, New Westminster, British Columbia, Canada., Galbraith P; British Columbia Cancer - Abbotsford, The University of British Columbia, Abbotsford, British Columbia, Canada., Al Tourah AJ; British Columbia Cancer - Surrey, The University of British Columbia, Surrey, British Columbia, Canada., Dueck G; British Columbia Cancer - Kelowna, The University of British Columbia, Kelowna, British Columbia, Canada., Noble MC; Royal Columbian Hospital, New Westminster, British Columbia, Canada., Ramadan KM; St. Paul's Hospital, The University of British Columbia, Vancouver, British Columbia, Canada., Tsang P; Division of Hematology, Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; Richmond Hospital, Richmond, British Columbia, Canada., Hardy E; Tom McMurtry & Peter Baerg Cancer Centre, Vernon Jubilee Hospital, British Columbia Cancer, The University of British Columbia, Vernon, British Columbia, Canada., Sehn LH; British Columbia Cancer - Vancouver, The University of British Columbia, Vancouver, British Columbia, Canada., Toze CL; Division of Hematology, Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Cancer - Vancouver, The University of British Columbia, Vancouver, British Columbia, Canada; Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, British Columbia, Canada. Electronic address: ctoze@bccancer.bc.ca.
Publikováno v:
Leukemia research [Leuk Res] 2021 Apr; Vol. 103, pp. 106538. Date of Electronic Publication: 2021 Feb 18.
Autor:
Villa D; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada., Savage KJ; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada., Toze CL; Leukemia/Bone Marrow Transplant Program of BC, Vancouver Coastal Health/University of British Columbia/BC Cancer Agency, Vancouver, BC, Canada.; Division of Hematology, Vancouver General Hospital, Vancouver Coastal Health/University of British Columbia, Vancouver, BC, Canada; and., Song K; Leukemia/Bone Marrow Transplant Program of BC, Vancouver Coastal Health/University of British Columbia/BC Cancer Agency, Vancouver, BC, Canada.; Division of Hematology, Vancouver General Hospital, Vancouver Coastal Health/University of British Columbia, Vancouver, BC, Canada; and., den Brok WD; Division of Medical Oncology, Fraser Valley Centre, BC Cancer Agency, Surrey, BC, Canada., Freeman CL; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, BC, Canada.; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.; Leukemia/Bone Marrow Transplant Program of BC, Vancouver Coastal Health/University of British Columbia/BC Cancer Agency, Vancouver, BC, Canada.; Division of Hematology, Vancouver General Hospital, Vancouver Coastal Health/University of British Columbia, Vancouver, BC, Canada; and.
Publikováno v:
Blood advances [Blood Adv] 2020 Aug 11; Vol. 4 (15), pp. 3486-3494.
Autor:
Hoofd C; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Huang SJ; Leukemia/Bone Marrow Transplant Program of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Gusscott S; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Lam S; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Wong R; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Johnston A; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Scott DW; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Bruyere H; Division of Hematology and the Cytogenetics Laboratory, Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Gillan TL; Division of Hematology and the Cytogenetics Laboratory, Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Toze CL; Leukemia/Bone Marrow Transplant Program of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada., Gerrie AS; Leukemia/Bone Marrow Transplant Program of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Weng AP; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: aweng@bccrc.ca.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2020 Apr; Vol. 22 (4), pp. 571-578. Date of Electronic Publication: 2020 Feb 06.
Autor:
Huang SJ; Division of Hematology, Vancouver General Hospital, University of British Columbia, Canada., Gerrie AS; Division of Hematology, Vancouver General Hospital, University of British Columbia, Canada; British Columbia Cancer - Vancouver, University of British Columbia, Vancouver, British Columbia, Canada., Young S; Pathology and Laboratory Medicine, British Columbia Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Tucker T; Pathology and Laboratory Medicine, British Columbia Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Bruyere H; Division of Pathology and Laboratory Medicine, Cytogenetics Laboratory, Vancouver General Hospital, University of British Columbia, Canada., Hrynchak M; Molecular Cytogenetic Laboratory, Royal Columbian Hospital, University of British Columbia, New Westminster, British Columbia, Canada., Galbraith P; British Columbia Cancer - Abbotsford, University of British Columbia, Abbotsford, British Columbia, Canada., Al Tourah AJ; British Columbia Cancer - Surrey, University of British Columbia, Surrey, British Columbia, Canada., Dueck G; British Columbia Cancer - Kelowna, University of British Columbia, Kelowna, British Columbia, Canada., Noble MC; Royal Columbian Hospital, New Westminster, British Columbia, Canada., Ramadan KM; St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Tsang P; Division of Hematology, Vancouver General Hospital, University of British Columbia, Canada; Richmond Hospital, Richmond, British Columbia, Canada., Hardy E; Tom McMurty & Peter Baerg Cancer Centre, Vernon Jubilee Hospital, Vernon, British Columbia, Canada., Sehn L; British Columbia Cancer - Vancouver, University of British Columbia, Vancouver, British Columbia, Canada., Toze CL; Division of Hematology, Vancouver General Hospital, University of British Columbia, Canada; British Columbia Cancer - Vancouver, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: ctoze@bccancer.bc.ca.
Publikováno v:
Leukemia research [Leuk Res] 2020 Apr; Vol. 91, pp. 106335. Date of Electronic Publication: 2020 Feb 24.
Autor:
Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. a.rio-machin@qmul.ac.uk., Vulliamy T; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK. t.vulliamy@qmul.ac.uk., Hug N; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Walne A; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Tawana K; Department of Haematology, Addenbrooke's Hospital, Cambridge, UK., Cardoso S; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Ellison A; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Pontikos N; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Tummala H; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Al Seraihi AFH; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Alnajar J; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK., Bewicke-Copley F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Armes H; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Barnett M; The Leukemia/BMT Program of British Columbia, Division of Hematology, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Bloor A; Department of Haematology, Christie Hospital, Manchester, UK., Bödör C; MTA-SE Lendulet Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Bowen D; Department of Haematology, St James's University Hospital, Leeds, UK., Fenaux P; Service d'hématologie Séniors, Hôpital St Louis/Université Paris, Paris, France., Green A; National Centre for Medical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland., Hallahan A; Children's Health Queensland Hospital and Health Service, Queensland Children's Hospital, South Brisbane, QLD, Australia., Hjorth-Hansen H; Department of Hematology, St Olavs Hospital and Institute of Cancer Research and Molecular Medicine (IKM) Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Hossain U; Department of Haematology, Whipps Cross Hospital, Barts NHS Trust, London, UK., Killick S; Department of Haematology, The Royal Bournemouth Hospital NHS Foundation Trust, Bournemouth, UK., Lawson S; Department of Haematology, Birmingham Children's Hospital, Birmingham, UK., Layton M; Centre for Haematology, Imperial College London, Hammersmith Hospital, London, UK., Male AM; Clinic Genetics Unit, Great Ormond Street Hospital, London, UK., Marsh J; Department of Haematological Medicine, Haematology Institute, King's College Hospital, London, UK., Mehta P; Bristol Haematology Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Mous R; UMC Utrecht Cancer Center, Universitair Medisch Centrum Utrecht, Huispostnummer, Utrecht, Netherlands., Nomdedéu JF; Laboratori d´Hematologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Owen C; Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB, Canada., Pavlu J; Centre for Haematology, Imperial College London, Hammersmith Hospital, London, UK., Payne EM; Department of Haematology, UCL Cancer Institute, University College London, London, UK., Protheroe RE; Bristol Haematology Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Preudhomme C; Laboratory of Hematology, Biology and Pathology Center, Centre Hospitalier Regional Universitaire de Lille, Lille, France.; Jean-Pierre Aubert Research Center, INSERM, Universitaire de Lille, Lille, France., Pujol-Moix N; Laboratori d´Hematologia, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain., Renneville A; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Russell N; Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Saggar A; Clinical Genetics, St George's Hospital Medical School, London, UK., Sciuccati G; Servicio de Hematologia y Oncologia, Hospital de Pediatría 'Prof. Dr. Juan P. Garrahan', Ciudad Autonoma de Buenos Aires, Argentina., Taussig D; Haemato-oncology Department, Royal Marsden Hospital, Sutton, UK., Toze CL; The Leukemia/BMT Program of British Columbia, Division of Hematology, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Uyttebroeck A; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Vandenberghe P; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Schlegelberger B; Institut für Humangenetik, Medizinische Hochschule Hannover, Hannover, Germany., Ripperger T; Institut für Humangenetik, Medizinische Hochschule Hannover, Hannover, Germany., Steinemann D; Institut für Humangenetik, Medizinische Hochschule Hannover, Hannover, Germany., Wu J; British Columbia Children's Hospital, Vancouver, BC, Canada., Mason J; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Page P; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Akiki S; Department of Laboratory Medicine & Pathology, Qatar Rehabilitation Institute, Hamad Bin Khalifa Medical City (HBKM), Doha, Qatar., Reay K; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK., Cavenagh JD; Department of Haematology, St Bartholomew's Hospital, Barts NHS Trust, London, UK., Plagnol V; Genetics Institute, University College London, London, UK., Caceres JF; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Fitzgibbon J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. j.fitzgibbon@qmul.ac.uk., Dokal I; Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, UK. i.dokal@qmul.ac.uk.; Barts Health NHS Trust, London, UK. i.dokal@qmul.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Feb 25; Vol. 11 (1), pp. 1044. Date of Electronic Publication: 2020 Feb 25.